1-(6-(5-chloro-2-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-3-methyl-1H-imidazo[4,5-c]pyridin-2(3H)-one

ID: ALA4474551

PubChem CID: 155537238

Max Phase: Preclinical

Molecular Formula: C20H13ClFN5O

Molecular Weight: 393.81

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c(=O)n(-c2cc(-c3cc(Cl)ccc3F)nc3[nH]ccc23)c2ccncc21

Standard InChI:  InChI=1S/C20H13ClFN5O/c1-26-18-10-23-6-5-16(18)27(20(26)28)17-9-15(25-19-12(17)4-7-24-19)13-8-11(21)2-3-14(13)22/h2-10H,1H3,(H,24,25)

Standard InChI Key:  HESAPDRVFTXZTE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   22.2237   -4.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2226   -5.4090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9306   -5.8179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9288   -4.1806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6374   -4.5858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6377   -5.4090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4207   -5.6632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.9044   -4.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4203   -4.3313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9264   -3.3634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5164   -5.8173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8088   -5.4064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1012   -5.8138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1001   -6.6318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8125   -7.0408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5171   -6.6311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2256   -7.0383    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.5829   -2.8838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3280   -2.1074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2607   -2.8878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5145   -2.1095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9679   -1.5025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1674   -1.6727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9164   -2.4552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4647   -3.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3608   -3.1342    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8065   -1.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3940   -5.4043    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  2 11  1  0
 16 17  1  0
 10 18  1  0
 18 19  1  0
 19 21  1  0
 20 10  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 18 26  2  0
 19 27  1  0
 13 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4474551

    ---

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.81Molecular Weight (Monoisotopic): 393.0793AlogP: 4.06#Rotatable Bonds: 2
Polar Surface Area: 68.50Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.48CX LogP: 3.70CX LogD: 3.70
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.25

References

1. Wang H, Lawson JD, Scorah N, Kamran R, Hixon MS, Atienza J, Dougan DR, Sabat M..  (2016)  Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors.,  26  (17): [PMID:27460209] [10.1016/j.bmcl.2016.07.030]

Source